Disclosed herein are methods for diagnosing and/or treating inflammatory bowel diseases associated with elevated activity or expression of IL 34. Also disclosed are pharmaceutical compositions containing an inhibitor of IL 34 useful for treating inflammatory bowel diseases and manufacture of medicaments containing an inhibitor of IL 34 to be used in treating inflammatory bowel disease.